Application of Biomarkers to Clinical Trials in Systemic Sclerosis.

Author: R. Lafyatis
Date Published: November-2011
Source: BioPortfolio

Important clinical advances in the treatment of systemic sclerosis have been made, yet fibrotic disease remains largely untreatable. Optimal design of clinical trials to test new therapeutics for fibrotic disease features has suffered from dual difficulties in patient selection and patient evaluation.


AddThis Social Bookmark Button